PODIATRY CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

The clinic’s name emphasizes its focus on foot and ankle medicine and signals clinical specialization and surgical capability. We operate in the medical services sector as a specialized podiatry practice in Houston, Texas, launching in 2026. Our core services span routine podiatric care, advanced reconstructive and elective foot and ankle surgery, and diagnostic imaging and testing. We use a fee-for-service revenue model and are staffed by board-certified specialists working with the latest diagnostic and surgical technology to deliver measurable, high-quality patient outcomes. One line: specialized foot and ankle care, surgical and non-surgical, in Houston.

Day-to-day activities include outpatient clinics, surgical procedures, diagnostic imaging, pre-op and post-op care, and coordinated referrals with primary care and endocrinology for complex cases. What sets us apart is the combination of board-certified clinicians, up-to-date diagnostics, and a care pathway optimized for outcomes and surgical throughput. We target Houston-area patients with foot and ankle conditions—from routine care to complex surgery—and referring physicians seeking predictable surgical partners. Short-term goals: open in 2026 and establish referral pipelines; long-term goal: achieve $6,949,000 in annual revenue within five years. One line: open in 2026, build referrals, hit $6,949,000 in year five.

Problem

Millions of Americans suffer foot and ankle conditions that limit mobility and increase risk of falls and infections; care is fragmented and delays worsen outcomes.

In Houston, specialized podiatric care for diabetic populations and high-performance athletes is inconsistent: patients face repeated visits, dispersed referrals, and variable diabetic foot management that raise complication rates and costs.

Existing providers rarely combine advanced diagnostics, board-certified specialists, and coordinated care under a single fee-for-service clinic; this gap drives poor outcomes today and creates demand for a consolidated, outcome-focused practice launching in 2026 aiming to reach $6,949,000 annual revenue within five years.

Solution

Millions of Americans have foot and ankle pain that limits mobility and raises long‑term costs; care is fragmented and delays diagnosis, especially for complex diabetic and sports cases. We close that gap by delivering an integrated clinic that combines diagnosis, treatment, and prevention under one roof, restoring function and reducing repeat visits.

Core on‑site services include digital X‑ray and diagnostic ultrasound, evidence‑based non‑invasive therapies, minimally invasive surgery, integrated wound care, and custom orthotics; each patient receives a personalized care plan focused on outcomes. This integrated model supports a target of $2,003,000 revenue by year two.

Mission Statement

We empower patients to overcome pain and regain active lives by combining advanced diagnostics, board-certified expertise, and personalized treatment plans. We commit to expert, compassionate care that focuses on lasting health, mobility, and measurable outcomes. We aim to be the region’s premier podiatry provider by putting each patient first and tailoring every plan to their specific goals.

Key Success Factors

Success depends on our clinical team, capitalized technology, fast breakeven, steady referrals, and high utilization.

• Board-certified specialists delivering clinical excellence and patient trust.
• $343,000 advanced medical technology enabling higher-quality procedures and throughput.
• Breakeven in two months preserving cash flow and supporting rapid scale.
• Robust physician referral network plus a $4,000/month marketing budget securing steady patient volume.
• 90% utilization (general podiatry by 2030) driving margin expansion and the 11.23% ROE.

Financial Summary

The clinic reaches breakeven in Feb-26 and delivers rapid payback and scalable profits.

Financial needs: minimum cash required $733,000 and total initial CAPEX $343,000; returns: IRR 11.73%, payback 16 months.

Overall outlook: strong growth to $6.95M revenue and $4.49M EBITDA by Year 5.

Funding Requirements

We need $733,000 total to fund clinic buildout, equipment, and working capital while ramping to Year 1 revenue of $1,074,000 and EBITDA of $277,000; breakeven is expected in February 2026, full payback within 16 months, IRR 11.73%, Year 5 revenue $6,949,000 and EBITDA $4,490,000.